Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/1637890/000119312520084305/d861749d20f.htm
June 2022
May 2022
March 2022
March 2022
February 2022
January 2022
December 2021
December 2021
December 2021
November 2021
Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/1637890/000119312520084305/d861749d20f.htm
Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Celyad S.A..
Celyad S.A.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 20-F Annual Report
Material Contracts, Statements, Certifications & more
Celyad S.A. provided additional information to their SEC Filing as exhibits
Ticker: CYAD
CIK: 1637890
Form Type: 20-F Annual Report
Accession Number: 0001193125-20-084305
Submitted to the SEC: Wed Mar 25 2020 7:32:11 AM EST
Accepted by the SEC: Wed Mar 25 2020
Period: Tuesday, December 31, 2019
Industry: Pharmaceutical Preparations